AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2637-8892/032
Department of Psychology, Oregon , USA.
*Corresponding Author: Eric Arthur Blair, Department of Psychology, Oregon, USA.
Citation: Eric Arthur Blair (2018) Immune deficiency derive a favorable response to IVIg in PANDAS, J.Psychology and Mental Health Care. 2(3); DOI: 10.31579/2637-8892/032
Copyright: © Eric Arthur Blair. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 10 May 2018 | Accepted: 21 June 2018 | Published: 06 July 2018
Keywords: pediatric autoimmune; neuropsychiatric disorder; hemolytic streptococcal infection
For two decades, pediatric autoimmune neuropsychiatric disorder associated with group a beta hemolytic streptococcal infection (PANDAS) has been treated with high-dose intravenous immune globulin (IVIg) therapy based upon the understanding that the disorder is partly due to post-infectious dysimmunity.
Introduction: For two decades, pediatric autoimmune neuropsychiatric disorder associated with group a beta hemolytic streptococcal infection (PANDAS) has been treated with high-dose intravenous immune globulin (IVIg) therapy based upon the understanding that the disorder is partly due to post-infectious dysimmunity.
Study Aims: To summarize literature cases of PANDAS treated with IVIg therapy.
Methods: A search for publications documenting the experience of PANDAS treated with IVIg therapy was carried out in the English-speaking medical literature. This yielded seven articles comprising an observational study (114 patients), a randomized control trial (9 patients), five small case series (21 patients), and a single case abstract, together documenting the experience of 145 published children who met established criteria for the diagnosis of PANDAS and were treated with IVIg therapy for neuropsychiatric symptoms. An analysis of their findings was performed contrasting and combining clinical characteristics and outcomes of cases in each study, and generalizing information with mean values for continuous variables and percentages for character values.
Results: Sixty percent of children showed overall clinical improvement, 24
A search for publications related to the case reports of children with PANDAS who underwent treatment with IVIg therapy was carried out on-line in PubMed. This yielded seven articles [8-14] to which an eighth study [15] was added. Together the papers document 145 children who met established criteria [5] for the diagnosis of PANDAS and received treatment with IVIg therapy for neuropsychiatric symptoms. The cohort of 145 children described in Table 1 was comprised of one large observational study of 114 children all of whom were treated with IVIg [15], a single randomized control trial (RCT) of nine children comparing IVIg to placebo and plasma-exchange (PE) [9], three small case series totaling 21 children [8,11-14]; and a case abstract [10]. Treatment with IVIg was generally deemed necessary because of neuropsychiatric symptoms refractory to maximal conservative management that typically included prophylactic antibiotics and psychotropic medications.
Clinical demographical characteristics at baseline such as age, sex, duration of PANDAS and IVIg treatment, dosage, regimens, and patient outcomes were abstracted in different studies and analyzed for mean values and associated percentages for continuous, categorical and discrete values.
Literature Review
Allen and colleagues [8] reported successful treatment of symptomatic tics and OCD in a child with GABHS infection complicating Tourette’s syndrome with IVIg in conjunction with penicillin prophylaxis. Perlmutter and colleagues [9] conducted a RCT comparing the outcome of OCD and tics among 29 children with PANDAS randomized to plasma exchange PE (10 children), IVIg (nine children) or saline solution placebo (10 children). The authors noted global score changes of 48% and 41% respectively at one month after treatment with 10 to 12 days of PE or 2 days of IVIg, compared to 87.5% and 77.7% in those respectively treated with PE or IVIg in open label at one year. Harsh and colleagues [10] reported a child with PANDAS in whom immunologic evaluation disclosed low IgG2/IgG4 subclass levels, suboptimal response to pneumococcal vaccine and rapid decline of pneumococcal antibody titers with low levels of proinflammatory cytokines (tumor necrosis factor [TNF]-a, interleukin [IL]1-b, and 12p40) to liposaccharide without Toll-like receptor (TLR)4 polymorphisms (Asp299Gly and Thr399lle). Treatment with IVIg was associated with near complete resolution of Sino pulmonary infection and symptoms of PANDAS. Thirty-two additional children with PANDAS treated successfully with IVIg were reported in five cases series [11-14]. Bouboulis and Mast [14] noted the favorable impact of IVIg on neuropsychiatric manifestations of PANDAS and humoral deficiency in the patients however the nature and extent of the latter was not described. Younger and colleagues [15] extended the findings of Bouboulis and Mast [14] noting low serum immunoglobulin levels in any category in 52.56%, and the favorable prognosis of children with baseline Ig deficiencies presumably in which IVIg acted as both replacement therapy and immune modulator.
Statistical Analysis
Table 1 and Table 2 summarize the clinical characteristics and outcome of the combined cohort of study patients. The male: female ratio was 1.9:1 with mean age 10.5 years, and mean duration of neuropsychiatric symptoms of 3.7 years before treatment with IVIg. Among the 145 children that comprised the study cohort, 120 (83%) received IVIg therapy at doses between 1.0 and 2.0 grams per kilogram administered every 1 to 2 months for a mean duration of 15.3 months (range 0.03 - 61.79 months) for refractory neuropsychiatric symptoms associated with PANDAS; 19 (13%) children received a single course of therapy in the first month.
Altogether, 87 (60%) were clinically improved, 35 (24%) achieved remission, and 14 (10%) were unchanged or worse at final assessment in the one large observational study [15]. Baseline Ig levels were documented in only two studies showing low IgG subclass 2 and 4 levels [10], and low levels of serum IgG subclasses, total IgG, IgM and IgA respectively in 26.47%, 25.51%, 16.28%, and 10.48% of cases [15]. Among 114 patients [15], 49 (35%) had low baseline Ig levels. Of 22 patients (19.3%) who achieved remission, all 22 (100%) had low baseline IgG (20 patients) or IgG subclass levels (2 patients), alone (8 patients) or together (6 patients) or in association with reduced IgA or IgM levels (8 patients), indicative of humoral deficiency prior to IVIg treatment [15]. One reported patient who achieved remission [10] had combined IgG2/4 subclass deficiency.
Low levels of IgA (p < 0>
Mild adverse effects of treatment so noted in 16% of patients in the one large observational study [15] included exacerbation of migraine headache or flu symptoms at the beginning of therapy that did not preclude ongoing treatment and was generally managed with slowing the rate of infusion, vigorous hydration, or a change in IVIg product.
Intravenous Ig provides replacement Ig in immunodeficiency and immunomodulation in the treatment of inflammatory autoimmune pediatric diseases [16]. From immunodeficiency to autoimmunity, the dynamic immunologic basis of PANDAS highlights the broad potential of high-dose IVIg therapy. One small early published RCT [9] and clinically similar case reports [8;10-14] demonstrated improvement or remission similar to a recent large observational study [15] that showed benefit of IVIg for up to 84% of children with PANDAS concomitant with, or following treatment at one-year final assessment [15].
Our study had several limitations mainly associated with lack of uniformity within and among the published cases of PANDAS that precluded statistically meaningful comparisons. First, the dose, duration of treatment and timing of IVIg therapy was not uniform with some patients treated for one month and others repeatedly. Second, there was lack of uniform assessment of response to IVIg with employment of different methods of scoring. A change in a global assessment score summing OCD symptoms, tic severity, global measures of symptoms severity and psychosocial functioning were used in the RCT [9], while quartile scales of percentage improvement were employed in the observational study [15] in assessing response to treatment at one month and one-year follow-up. None of the patients described in case reports were objectively scored at onset or after one month or 12 months of treatment. Third, it was not possible to ascertain the beneficial effects of concomitantly prescribed medications such as chronic or prophylactic antibiotics or psychotropic agents in the response to IVIg. Fourth, there were no data in regard to patient's clinical status between the long intervals of assessment. Neither was it possible to ascertain whether unrelated bouts of exacerbation and improvement may have influenced the response attributed to IVIg. Fifth, with a mean treatment period of 15.7months (SD = 13.8 months) in the observational study [15], nearly half of patients were assessed while receiving IVIg leading to a possible excess of positive cases compared to those treated for a shorter time. Lastly, baseline Ig status was described in only two studies [10,15], including one that selected patients for treatment with IVIg because of immune deficiency [14] but did not provide further detailed information relevant to it.
The nosology and classification of autoimmune neuropsychiatric disorders is rapidly evolving [17], and the recognition that some affected children have infectious and immunologic triggers emphasizes the importance of new avenues of treatment. Intravenous Ig is a safe and useful adjunctive therapy in the treatment of refractory neuropsychiatric symptoms due to PANDAS and its variants. Children with PANDAS, often with baseline humoral immune deficiency derived a favorable response to IVIg in PANDAS at 12 months follow up consistent with its role in Ig replacement and immune modulation. While its use has not been substantiated in a large RCT, our findings support the use of IVIg early in the course of the disease and continued until significant improvement or remission is achieved often without serious side-effects. There is an urgent need for standardized guidelines to address the selection of patients and the most appropriate dosing regimens in those with refractory neuropsychiatric symptoms due to PANDAS.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
